Slow acetylator NAT2 (N-acetyltransferase 2) variants and GSTM1 (glutathione S-transferase mu 1) null genotypes are examples of possible BC genetic risk factors and, although they might not directly lead to BC, they may increase the susceptibility for external carcinogens such as tobacco smoke [17]. This evidence concerns the gene NAT2 and breast cancer.